Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A32BB | RL |
Adminstered expired vaccine; This non-serious case was reported by a other health professional via sales rep and described the occurrence of expired vaccine used in a 7-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number A32BB) for prophylaxis. On 02-SEP-2025, the patient received Pediarix (right thigh). On 02-SEP-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: Adminstered expired vaccine). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-SEP-2025 The reporter reported that patient had administered expired vaccine which led to expired vaccine used.